Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Allergence
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Allergence
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Search
Tag: Investigational New Drug Application (IND)
Toothpaste Therapy for Food Allergies Takes Another Step Forward
Dave Bloom
-
2021/02/05
FDA accepts IND application by Intrommune Therapeutics.
FDA Opens Door for Clinical Development of Aquestive Therapeutics Anaphylaxis Treatment
News Wire ~ 3rd Party Press Release
-
2020/02/06
Emergency epinephrine candidate dissolves in the mouth.
Intrommune’s Food Allergy Toothpaste Therapy to Advance to Clinical Trials
Dave Bloom
-
2020/01/14
See the interview with the CEO as well as a new video describing the therapy here.
Bryn Pharma Completes Dosing in Pivotal Clinical Trial Designed to Support...
News Wire ~ 3rd Party Press Release
-
2019/10/10
Nasal Spray Product is Disruptive Innovation for People at Risk of Anaphylaxis.
Aimmune to Begin Phase 2 Trials of Egg Allergy OIT Candidate
News Wire ~ 3rd Party Press Release
-
2018/12/20
AR201 for Egg Allergy Phase 2 Initiation Planned for 2019.
ConsortiaTX Awarded Exclusive License for Food Allergy Microbial Therapy
News Wire ~ 3rd Party Press Release
-
2018/10/24
The company is developing therapies for food allergies based on bacteria found in the human gut microbiome.
Company Developing Peanut Immunotherapy Toothpaste Meets with FDA
News Wire ~ 3rd Party Press Release
-
2018/09/06
"INT301 has the potential to be the first allergy immunotherapy treatment that easily integrates into a person’s daily routine."
Intrommune Therapeutics Seeks Crowdfunding for Novel Toothpaste Immunotherapy
Dave Bloom
-
2018/04/24
The company is developing a therapy called "Oral Mucosal Immunotherapy".